Dixon Tech Rises 6% on Investec's Buy Call

Dixon Technologies shares rose 6% extending gains for the fifth straight session and up 10% in five days after Investec raised its target price to ₹16,200 implying 30% upside and increased EPS estimates by 6-8% for FY27 and FY28. Mobile exports accelerating Chinese EMS players are gradually losing market share to Indian peers like Dixon. As global brands shift manufacturing away from China Dixon is the biggest beneficiary winning more smartphone assembly contracts every quarter. Specialty EMS acquisition Dixon recently entered the specialty electronics manufacturing services business a higher margin segment covering complex electronics beyond just smartphones. Investec says this could lead to further earnings estimate upgrades. Vivo JV coming We covered this earlier government approval for Dixon Vivo JV is near. Once operational it adds massive guaranteed smartphone volumes from one of India's largest handset brands. Investec expects EBITDA to stay flat in H1 FY27 due to PLI scheme expiry but sees strong earnings growth from H2 FY27 onwards as new businesses ramp up. This is a classic buy the dip before the-recovery setup weak H1 creates entry opportunity before H2 acceleration. Production Linked Incentive the government pays companies cash incentives for hitting manufacturing targets. When PLI expires companies lose this extra income temporarily causing a short term earnings dip before underlying business growth compensates. Smart investors look through PLI expiry dips to underlying business momentum. Dixon's 6% rally on Investec's upgraded target taught me that electronics manufacturers winning market share from Chinese peers through mobile exports, specialty EMS and strategic JVs can deliver multi-year earnings growth, making it essential to track PLI timelines, export volume trends and new segment acquisitions for stocks like $DIXON n, $AMBER and $KAYNES before investing.